Mitochondrial targeting and a novel transmembrane arrest of Alzheimer's amyloid precursor protein impairs

Hindupur K Anandatheerthavarada1, Gopa Biswas, Marie-Anne Robin

  • 1Department of Animal Biology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Insights

Alzheimer's amyloid precursor protein (APP) targets neuronal mitochondria, contributing to mitochondrial dysfunction and impaired energy metabolism in Alzheimer's disease models. This discovery reveals a novel role for APP in brain mitochondria.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Alzheimer's disease (AD) is linked to amyloid beta (Abeta) peptides derived from amyloid precursor protein (APP).
  • APP is typically a plasma membrane protein.
  • The exact cellular localization and function of APP in neuronal mitochondria are not fully understood.

Purpose of the Study:

  • To investigate the mitochondrial targeting of APP in neuronal cells.
  • To elucidate the mechanism and consequences of APP accumulation in mitochondria.
  • To explore the role of APP in mitochondrial dysfunction in Alzheimer's disease.

Main Methods:

  • Utilized a transgenic mouse model for Alzheimer's disease.
  • Employed chemical cross-linking and immunoelectron microscopy to study mitochondrial APP.
  • Conducted mutational studies to identify critical domains of APP for mitochondrial targeting and function.

Main Results:

  • Demonstrated that APP is targeted to mitochondria in cortical neuronal cells and specific brain regions of AD mouse models.
  • Identified positively charged residues (40, 44, 51) as crucial for the mitochondrial-targeting signal of APP.
  • Showed that APP accumulates in mitochondria in a transmembrane-arrested form, interacting with translocase proteins.
  • Found that full-length APP accumulation in mitochondria, but not variants lacking the acidic domain, leads to mitochondrial dysfunction and impaired energy metabolism.

Conclusions:

  • Established that APP is targeted to neuronal mitochondria under physiological and pathological conditions.
  • Revealed a novel mechanism involving APP's transmembrane arrest in mitochondria.
  • Linked mitochondrial APP accumulation to impaired energy metabolism, suggesting a new pathway in Alzheimer's pathogenesis.

Related Concept Videos

Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Protein Transport into the Inner Mitochondrial Membrane01:34

Protein Transport into the Inner Mitochondrial Membrane

Nuclear encoded mitochondrial precursors are imported to the inner membrane in a multistep process involving two separate translocons, TIM22 and TIM23. TIM23 is a cation-selective pore that remains closed by the N terminal segment of the protein. Negative charges on the TIM23 act as a receptor for the incoming precursor, pulling the positively charged matrix-targeting sequence for peptide insertion and translocation.
Transport of mitochondrial precursors across the TIM23 channel is driven by...